News & Updates
Filter by Specialty:
Show Multimedia Only
Daromun plus surgery improves survival in resectable melanoma
14 Jun 2024
byStephen Padilla
Use of neoadjuvant daromun in addition to surgery is safe and provides survival benefits in patients with resectable, locally advanced melanoma, results of the PIVOTAL study have shown.
Daromun plus surgery improves survival in resectable melanoma
14 Jun 2024
Nivolumab plus chemo offers prolonged survival in resectable NSCLC
14 Jun 2024
byStephen Padilla
Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate 816 study.
